Our team is actively involved in clinical trials and medical research. Apart from lectures and presentations at various conferences, we have published several research articles in national and international medical journals.
Completed Trials :
A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15 cm2 in Patients With Severe Dementia of the Alzheimer’s Type(Novartis)
An open-Label, Balanced, Randomized, Single-dose, Two-treatment, Two-Period, Two-Sequence, Two-Wat crossover, Oral Bioequivalance Study of Cladribine generic tablets and Mavenclad in patients with highly active Multiple Sclerosis
Ongoing Trials :
OPERETTA2 – A Phase III Multicenter, Randomized, Double-blind, Double-dummy Study To Evaluate Safety And Efficacy Of Ocrelizumab In Comparison With Fingolimod In Children And Adolescents With Relapsing-remitting Multiple Sclerosis
Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders
Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton’s Tyrosine Kinase (BTK) Inhibitor Tolebrutinib